https://www.selleckchem.com/pr....oducts/cilofexor-gs-
003, body mass index p=0.04 adjusted for age) and were more likely to present with left ventricular outflow tract obstruction (p=0.0483). Patients with sarcomere mutation negative HCM present at an older age and are more obese compared with patients with sarcomere mutation positive HCM. The role of ageing and obesity in asymmetric myocardial hypertrophy warrants further investigation. Patients with sarcomere mutation negative HCM present at an older age and are more obese compared with patients with sarcomere mutation positive
Like
Comment
Share
